Table 1: Summary of characteristics of 91 studies included in a meta-analysis of laboratory values and mortality in COVID-19.
N | % | |
Year | ||
2020 | 96 | 100% |
Country | ||
China | 67 | 70% |
United States | 10 | 10% |
Italy | 8 | 8% |
Spain | 3 | 3% |
United Kingdom | 3 | 3% |
Iran | 1 | 1% |
Canada | 1 | 1% |
International | 1 | 1% |
Mexico | 1 | 1% |
Belgium | 1 | 1% |
Study type | ||
Retrospective cohort | 59 | 61% |
Case control | 22 | 23% |
Prospective cohort | 14 | 15% |
Ambispective cohort | 1 | 1% |
Patient type | ||
Inpatient | 69 | 72% |
ICU | 12 | 13% |
Inpatient/ICU | 9 | 9% |
Inpatient/Outpatient | 1 | 1% |
Unclear | 3 | 3% |
COVID-19: Novel coronavirus disease 2019; ICU: Intensive care unit.